Showing 301 - 320 results of 2,138 for search '"Chronic Myeloid Leukemia"', query time: 0.21s Refine Results
  1. 301
  2. 302
  3. 303
  4. 304
  5. 305

    Withdrawal syndrome after tyrosine kinase inhibitors discontinuation in patients with chronic myeloid leukemia by Ekaterina Yu. Chelysheva, Anna N. Petrova, Oleg A. Shukhov, Anastasiia V. Bykova, Irina S. Nemchenko, Margarita A. Gurianova, Nikolay N. Tsyba, Anna G. Turkina

    Published 2022-08-01
    “…Withdrawal syndrome (WS) a musculoskeletal pain after discontinuation of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukemia (CML) has been described in the treatment-free remission (TFR) studies. …”
    Get full text
    Article
  6. 306

    Avapritinib treatment of KIT D816V-mutant atypical chronic myeloid leukemia by Lyndsey Sandow, Michael Heinrich

    Published 2023-01-01
    “…Background: Atypical chronic myeloid leukemia (aCML) is a rare myelodysplastic/myeloproliferative neoplasm. …”
    Get full text
    Article
  7. 307

    Defective migration and dysmorphology of neutrophil granulocytes in atypical chronic myeloid leukemia treated with ruxolitinib by Lea Bornemann, Marc Schuster, Saskia Schmitz, Charlyn Sobczak, Clara Bessen, Simon F. Merz, Karl-Heinz Jöckel, Thomas Haverkamp, Matthias Gunzer, Joachim R. Göthert

    Published 2020-07-01
    “…Here, we apply this assay to study quantitively increased neutrophils of a patient suffering from a rare leukemia subtype, atypical chronic myeloid leukemia (aCML). Methods A 69-year-old male was analyzed in this study. …”
    Get full text
    Article
  8. 308

    Wnt/β-catenin pathway regulates <it>ABCB1</it> transcription in chronic myeloid leukemia by Corrêa Stephany, Binato Renata, Du Rocher Bárbara, Castelo-Branco Morgana TL, Pizzatti Luciana, Abdelhay Eliana

    Published 2012-07-01
    “…<p>Abstract</p> <p>Background</p> <p>The advanced phases of chronic myeloid leukemia (CML) are known to be more resistant to therapy. …”
    Get full text
    Article
  9. 309

    The Direct and Indirect Effects of Tyrosine Kinase Inhibitors on the Cardiovascular System in Chronic Myeloid Leukemia by Alessandro Costa, Raimondo Pittorru, Giovanni Caocci, Federico Migliore, Francesco Tona, Olga Mulas, Giorgio La Nasa

    Published 2023-07-01
    “…Since their introduction, tyrosine kinase inhibitors (TKIs) have radically changed the treatment paradigm of Chronic Myeloid Leukemia (CML), leading to deep and lasting molecular responses and profoundly influencing survival. …”
    Get full text
    Article
  10. 310
  11. 311
  12. 312

    Mutation resistant to tyrosine kinase inhibitors in chronic myeloid leukemia : about a case by Ibtissem KIHEL, Mourad NACHI, Badra ENTASOLTAN, Mohamed-Amine BEKADJA

    Published 2020-06-01
    “… Introduction - The management and long-term outcome of patients affected by chronic myeloid leukemia (CML) hadimproved considerably with the introduction in the 2000’s of tyrosine kinase inhibitors, that revolutionized the prognosis of the disease and improved overall the survival of patients. …”
    Get full text
    Article
  13. 313

    Dasatinib Induced Avascular Necrosis of Femoral Head in Adult Patient with Chronic Myeloid Leukemia by Mohamed A. Yassin, Abbas H. Moustafa, Abdulqadir J. Nashwan, Ashraf T. Soliman, Hatim El Derhoubi, Shehab F. Mohamed, Deena S. Mudawi, Sarah ELkourashy, Deena-Raiza Asaari, Hope-Love G. Gutierrez, Radwa M. Hussein, Mohamed Al Musharraf, Samah Kohla, Ahmed Elsayed, Nader Al-Dewik

    Published 2015-01-01
    “…Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by the presence of the Philadelphia (Ph) chromosome resulting from the reciprocal translocation t(9;22)(q34;q11). …”
    Get full text
    Article
  14. 314
  15. 315

    Cytogenetic Response Assessment to Imatinib Mesylate Therapy for Chronic Myeloid Leukemia in Iraqi Patients by Azhar M Haleem

    Published 2020-06-01
    Subjects: “…Chronic Myeloid Leukemia, BCR/ALB gene, Imatinib, Chromosomal Aberrations, FISH…”
    Get full text
    Article
  16. 316

    THE ROLE OF CYTOGENETICS AND MOLECULAR GENETICS IN DIAGNOSIS OF CHRONIC MYELOID LEUKEMIA AND MONITORING OF TREATMENT RESPONSE by Helena Podgornik, Tadej Pajič, Nadja Kokalj Vokač, Andreja Zagorac, Ruth Rupreht, Peter Černelč

    Published 2004-12-01
    “…<p>Background. Chronic myeloid leukemia serves as a model for the disease where the knowledge as well as the development of different new methods from molecular biology were successfully introduced into the clinical practice.…”
    Get full text
    Article
  17. 317
  18. 318
  19. 319
  20. 320